Impax Asset Management’s AbbVie ABBV Stock Holding History

Impax Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-120,000	Closed	-$10.7M	–	187
2017 Q3	$10.7M	Buy	+120,000	New	+$9.13M	0.61%	73
2016 Q1	–	Sell	-290,462	Closed	-$17.2M	–	205
2015 Q4	$17.2M	Buy	290,462 +40,097	+16%	+$2.31M	0.96%	40
2015 Q3	$13.6M	Buy	250,365 +79	+0%	+$5.14K	0.81%	50
2015 Q2	$16.8M	Buy	250,286 +49,719	+25%	+$3.25M	0.9%	42
2015 Q1	$11.7M	Sell	200,567 -210,020	-51%	-$12.7M	0.64%	56
2014 Q4	$26.9M	Buy	410,587 +90,174	+28%	+$5.68M	1.59%	16
2014 Q3	$18.5M	Buy	+320,413	New	+$17.8M	1.2%	28

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Impax Asset Management's ABBV Position: Q4 2017 in Review

Impax Asset Management sold out of AbbVie (ABBV) in Q4 2017, closing a stake of 120,000 shares — an estimated $10.7M sold.

Impax Asset Management first reported a position in ABBV in Q3 2014 and held it in 7 quarters. The position peaked at $26.9M in Q4 2014. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

Impax Asset Management reported no remaining AbbVie position as of Q4 2017 after selling out during the quarter.
Impax Asset Management sold 120,000 AbbVie shares in Q4 2017, an estimated $10.7M.
Impax Asset Management first reported a position in AbbVie in Q3 2014 and held it in 7 quarters.
Impax Asset Management's AbbVie position peaked at $26.9M in Q4 2014.
2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Impax Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.